Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran.

Rahmanzadeh, F; Malekpour, N; Faramarzi, A; Yusefzadeh, H

Rahmanzadeh, F; Malekpour, N; Faramarzi, A; Yusefzadeh, H.

Affiliation

Rahmanzadeh F; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
Malekpour N; Health Education Department, Urmia University of Medical Sciences, Health deputy, Urmia, Iran.
Faramarzi A; Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
Yusefzadeh H; Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran. yusefzadeh.h@umsu.ac.ir.

BMC Health Serv Res ; 23(1): 861, 2023 Aug 14.

Article in En | MEDLINE | ID: mdl-37580701

Subject(s)

COVID-19; Humans; COVID-19/diagnosis; COVID-19/epidemiology; Cost-Effectiveness Analysis; Iran/epidemiology; Sensitivity and Specificity; Cost-Benefit Analysis; Immunoglobulin G; Immunoglobulin M; COVID-19 Testing

Key words

COVID-19; Chest CT; Cost effectiveness analysis; IgM and IgG antibodies; Polymerase chain reaction (PCR)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Health_economic_evaluation / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google